Roche, Spark extend $4.3 bln takeover again, this time to Sept. 3

Madiha Shakeel July 31, 2019

ZURICH: Roche and Spark Therapeutics announced another extension of the Swiss drugmaker’s $4.3 billion takeover offer for the U.S. gene therapy specialist as regulatory reviews in the United States and Britain continue.

The offer for Spark shares now runs to Sept. 3, Roche said, adding terms and conditions are unchanged. “The parties remain committed to the transaction and are working cooperatively and expeditiously with the Federal Trade Commission and UK Competition and Markets Authority,” Roche said.

Copyright Reuters, 2019

  • Leave a Reply

    Your email address will not be published. Required fields are marked *